AMAG Pharmaceuticals Reaches Analyst Target Price
April 05, 2018 at 08:53 AM EDT
In recent trading, shares of AMAG Pharmaceuticals, Inc. (AMAG) have crossed above the average analyst 12-month target price of $20.80, changing hands for $21.00/share..